Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Junya Makiyama

Sapporo City General Hospital

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan Professors in Cell Biology Cell Biology professors in Japan

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Shigeo Fujii

Director

Osaka International Cancer Institute

JAPAN

View details

Yoshitaka Inoue

Kumamoto University Hospital

JAPAN

View details

Takashi Yoshioka

Fukushima Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Junya Makiyama

Research Interests

Make your next move.

Explore related searches

Articles (11)

Outcomes of patients aged 70 years or younger with aggressive ATL at core hospitals for ATL treatment in Tokyo

Significant detrimental impact of pre-transplant mogamulizumab on the post-transplant outcome with a short interval between the last mogamulizumab and transplantation

A Multicenter Real‐World Retrospective Study for Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, and Prednisolone for Previously Untreated Patients With CD30‐Positive Adult T‐Cell Leukemia‐Lymphoma

Mechanisms of action and resistance in histone methylation-targeted therapy

The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia–lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular Therapy

An update on the developments in the treatment of adult T-cell leukemia–lymphoma: current knowledge and future perspective

RE: Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report

Discordance in the morphologic diagnosis of lymphocytes in HTLV‐1‐infected individuals

Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study

Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma

Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis

Collaborators (3)

Shigeo Fujii

Yoshitaka Inoue

Takashi Yoshioka

Make your next move.